^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Bendeka (bendamustine rapid infusion)

    i
    Other names: EP-3102
    Associations

    News

    Trials
    Company:
    Eagle Pharma, SymBio Pharma, Teva
    Drug class:
    Alkylating agent
    Related drugs:
    Associations

    News

    Trials
    over1year
    Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma (clinicaltrials.gov)
    P1/2, N=37, Completed, SymBio Pharmaceuticals | Unknown status --> Completed
    Trial completion • Combination therapy
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    CD20 positive
    |
    Rituxan (rituximab) • bendamustine • Bendeka (bendamustine rapid infusion)